查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1455738

全球牛初乳市場 - 2023-2030

Global Bovine Colostrum Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球牛初乳市場規模達到32.1億美元，預計2030年將達到51.9億美元，2023-2030年預測期間CAGR為6.21%。

多年來，全球牛初乳市場經歷了顯著的成長和轉變，消費者高度採用牛初乳作為膳食補充劑，因為它是大量和微量營養素、免疫球蛋白和抗菌肽的豐富天然來源。活動，有助於促進整體健康和免疫支持。

此外，隨著消費者對特色營養產品的需求不斷成長，製造公司正在開發創新產品。例如，2022 年 11 月，PanTheryx 推出了 Life's First Naturals PRO 牛補充劑，這是一種專為醫療保健從業者管道配製的超強免疫支持和消化健康補充劑。

初乳和亞太地區的膳食補充劑在全球牛初乳市場中佔據主導地位，因為該地區的牛奶產量和需求量都很高，這與牛初乳產品的生產保持一致，因此有助於推動全球牛初乳產品的成長。牛初乳市場。

動力學

健康和保健趨勢的增加

消費者擴大尋求天然和營養補充劑來支持他們的整體健康。牛初乳是各種營養素和生物活性化合物的豐富來源，符合此需求，並有助於增強免疫系統和腸道健康。因此，健康和保健趨勢的上升有助於推動全球牛初乳市場的發展。

此外，製造公司正在其產品組合中推出新型初乳產品。例如，2022年5月，專門生產初乳的消化和免疫支持成分公司Pantheryx推出了一款含有益生菌菌株的初乳，用於兒童和成人膳食補充劑。新的配方能力可利用初乳和動物雙歧桿菌 BB-12、鼠李糖乳桿菌 LGG+、植物乳桿菌 HEAL9、副乾酪乳桿菌 8700:2 和枯草芽孢桿菌 DE111 等菌株生產組合產品。

初乳腺癌盛行率增加

益生菌紊亂可導致初乳腺癌，而消費者中初乳腺癌的盛行率正在上升。例如，根據世界衛生組織 (WHO) 的報告，大腸癌是全球第三大常見癌症，約佔所有癌症病例的 10%，也是全球癌症相關死亡的第二大原因。它主要影響老年人，大多數病例發生在 50 歲及以上的人群中。

此外，製造公司專注於開發各種產品以吸引更大的消費者群。例如，2022年11月，APS和凌陽宣佈建立多年策略夥伴關係，共同開發新的牛初乳產品。透過此策略合作，APS 將在 sunplus 的 natrapure cbps 奶粉中首次推​​出其新的初乳鹼性蛋白和免疫球蛋白配方。

乳糖不耐症盛行率上升

乳糖不耐症是一種消化系統疾病，身體無法消化乳糖，乳糖是牛奶和乳製品中發現的一種糖。根據 Medline Plus 2023 年的報告，患有乳糖不耐症的人數一直在增加。據估計，大約 65% 的人口在嬰兒期後消化乳糖的能力下降。這種情況在東亞地區尤其普遍。因此，這種高流行率可能會限制較小消費者群的市場。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 自然片段
  • 按表格列出的片段
  • 按配銷通路分類的片段
  • 按應用程式片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 健康和保健趨勢的增加
      • 初乳腺癌盛行率增加
    • 限制
      • 乳糖不耐症盛行率上升
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：本質

  • 有機的
  • 傳統的

第 8 章：按形式

  • 液體
  • 粉末
  • 膠囊
  • 平板電腦

第 9 章：按配銷通路

  • 大型超市/超市
  • 專賣店
  • 便利商店
  • 其他

第 10 章：按應用

  • 膳食補充劑
  • 功能性食品
  • 動物營養
  • 化妝品
  • 嬰幼兒配方奶粉
  • 藥品
  • 其他

第 11 章：按地區

  • 北美洲
    • 市場規模分析及年成長分析（%），按應用
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Colostrum BioTec GmbH
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Zuche Pharmaceuticals.
  • Biodane Pharma A/S
  • Agati Healthcare
  • Vivesa holding sro
  • Cure Nutraceutical PVT. LTD
  • PanTheryx, Inc.
  • NOW Health Group, Inc.
  • Sterling Technology
  • Farbest Brands

第 14 章：附錄

簡介目錄
Product Code: FB8180

Overview

Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2030, growing with a CAGR of 6.21% during the forecast period 2023-2030.

The global bovine colostrum market has witnessed significant growth and transformations over the years, as consumers are highly adopting this bovine colostrum as a dietary supplement as it is a rich natural source of macro- and micro-nutrients, immunoglobulins, and peptides with anti-microbial activity, and it helps to promote general health and immune support.

In addition, as the demand for specialty nutritious products is rising among consumers, manufacturing companies are developing innovative products. For instance, in November 2022, PanTheryx launched Life's First Naturals PRO bovine supplement, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

The dietary supplements of colostrum and Asia-Pacific region show the dominance in global bovine colostrum market, as the milk production rate and demand are high in this region, which aligns the production of bovine colostrum products, hence, it can help in driving the global bovine colostrum market.

Dynamics

Increase in Health and Wellness Trends

Consumers are increasingly seeking natural and nutritional supplements to support their overall well-being. Bovine colostrum, being a rich source of various nutrients and bioactive compounds, aligns with this demand, and also, helps in enhancing the immune system, and gut health. Hence, the rising health and wellness trends can contribute to driving the global bovine colostrum market.

Furthermore, manufacturing companies are launching novel colostrum products in their portfolios. For instance, in May 2022, Pantheryx, a digestive and immune support ingredients company specializing in colostrum, launched a colostrum with probiotic strains for children's and adults' dietary supplements. The new formulation capability creates combination products with colostrum and strains such as Bifidobacterium animalis BB-12, Lactobacillus rhamnosus LGG+, Lactobacillus plantarum HEAL9, Lactobacillus paracasei 8700:2, and B. subtilis DE111.

Increasing Prevalences Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with most cases occurring in people aged 50 and above.

In addition, manufacturing companies focus on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Rising Prevalence of Lactose Intolerance

Lactose intolerance is a digestive disorder where the body is unable to digest lactose, a type of sugar found in milk and dairy products. According to a report by Medline Plus in 2023, the number of people with lactose intolerance has been increasing. It is estimated that around 65% of the human population has a reduced ability to digest lactose after infancy. This condition is particularly prevalent in the East Asian region. As a result, this high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global bovine colostrum market is segmented based on nature, form, distribution channel, application, and region.

Increase in Adoption of Colostrum as a Dietary Supplement

The dietary supplements of colostrum have the maximum share in the global bovine colostrum market, as colostrum has high nutritional value, natural macro- and micro-nutrients, immunoglobulins, and others, the consumption of colostrum helps in improving the immune system to fight against diseases.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, The Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. it helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, Vivesa holding s.r.o., Cure Nutraceutical PVT. LTD, PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Farbest Brands

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global bovine colostrum market. Many countries have imposed lockdown restrictions which have impacted the distribution channel, exports, and imports of the products.

Additionally, COVID-19 has created opportunities for manufacturers to develop innovative products with beneficial effects and to support the market, for instance, in May 2020, The Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

By Nature

  • Organic
  • Conventional

By Bovine

  • Liquid
  • Powder
  • Capsules
  • Tablets

By Distribution Channel

  • Hypermarkets/Supermarkets
  • Specialty stores
  • Convenience stores
  • Others

By Application

  • Dietary Supplements
  • Functional Food
  • Animal Nutrition
  • Cosmetics
  • Infant Formula
  • Pharmaceuticals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Australian infant goat milk formula specialist Nuchev launches its first bovine products targeting school-going children and adults.
  • In April 2021, Kilyos Nutrition and Pantheryx are partnering for the research, development, and commercialization of bovine colostrum solutions in Brazil.

Why Purchase the Report?

  • To visualize the global bovine colostrum market segmentation based on nature, form, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of bovine colostrum market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global bovine colostrum market report would provide approximately 70 tables, 67 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Nature
  • 3.2.Snippet by Form
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increase in Health and Wellness Trends
      • 4.1.1.2.Increasing Prevalences of Colostrum Cancers
    • 4.1.2.Restraints
      • 4.1.2.1.Rising Prevalence of Lactose Intolerance
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Nature

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 7.1.2.Market Attractiveness Index, By Nature
  • 7.2.Organic*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Conventional

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Liquid*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Powder
  • 8.4.Capsules
  • 8.5.Tablets

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Hypermarkets/Supermarkets*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Specialty stores
  • 9.4.Convenience stores
  • 9.5.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Dietary Supplements*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Functional Food
  • 10.4.Animal Nutrition
  • 10.5.Cosmetics
  • 10.6.Infant Formula
  • 10.7.Pharmaceuticals
  • 10.8.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.arket Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Colostrum BioTec GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Zuche Pharmaceuticals.
  • 13.3.Biodane Pharma A/S
  • 13.4.Agati Healthcare
  • 13.5.Vivesa holding s.r.o.
  • 13.6.Cure Nutraceutical PVT. LTD
  • 13.7.PanTheryx, Inc.
  • 13.8.NOW Health Group, Inc.
  • 13.9.Sterling Technology
  • 13.10.Farbest Brands

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us